Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections

Annals of Internal Medicine

Volumn 167, Issue 6, 2017, Pages 365-374

  Beck, Roy W ^a   Riddlesworth, Tonya D ^a   Ruedy, Katrina ^a   Ahmann, Andrew ^b   Haller, Stacie ^c   Kruger, Davida ^d   McGill, Janet B ^e   Polonsky, William ^f   Price, David ^g   Aronoff, Stephen ^h   Aronson, Ronnie ⁱ   Toschi, Elena ^j   Kollman, Craig ^a   Bergenstal, Richard ^k  

^a JAEB CENTER FOR HEALTH RESEARCH   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Diabetes and Glandular Disease Clinic   (United States)

^d HENRY FORD HOSPITAL   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Behavioral Diabetes Institute   (United States)

^g DexCom Inc   (United States)

^h Research Institute of Dallas   (United States)

ⁱ LMC DIABETES AND ENDOCRINOLOGY   (Canada)

^j JOSLIN DIABETES CENTER   (United States)

^k INTERNATIONAL DIABETES CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; SHORT ACTING INSULIN; ANTIDIABETIC AGENT; BACTERIAL PROTEIN; DIVIB PROTEIN, BACILLUS SUBTILIS; GLYCOSYLATED HEMOGLOBIN; MEMBRANE PROTEIN;

ADULT; AGE; AGED; ARTICLE; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTINUOUS GLUCOSE MONITORING; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DISEASE DURATION; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NORTH AMERICA; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; THORAX PAIN; BLOOD; CHEMICALLY INDUCED; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; PATIENT SATISFACTION;

ADULT; AGED; BACTERIAL PROTEINS; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MEMBRANE PROTEINS; MIDDLE AGED; PATIENT SATISFACTION; QUALITY OF LIFE;

EID: 85029688306     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M16-2855     Document Type: Article

References (36)

1. Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care. 2011; 34:795-800. [PMID: 21335621] doi:10.2337/dc10-1989
2. Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, et al.; STAR 3 Study Group. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010; 363:311-20. [PMID: 20587585] doi:10.1056/NEJMoa1002853
3. Fonseca VA, Grunberger G, Anhalt H, Bailey TS, Blevins T, Garg SK, et al.; Consensus Conference Writing Committee. Continuous glucose monitoring: a consensus conference of the American Association of Clinical Endocrinologists and American College of Endocrinology. Endocr Pract. 2016; 22:1008-21. [PMID: 27214060] doi:10.4158/EP161392.CS
4. Gandhi GY, Kovalaske M, Kudva Y, Walsh K, Elamin MB, Beers M, et al. Efficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: a systematic review and meta-analysis of randomized trials. J Diabetes Sci Technol. 2011; 5: 952-65. [PMID: 21880239]
5. Hommel E, Olsen B, Battelino T, Conget I, Schütz-Fuhrmann I, Hoogma R, et al; SWITCH Study Group. Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study. Acta Diabetol. 2014; 51:845-51. [PMID: 25037251] doi:10.1007/s00592-014-0598-7
6. Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ. 2011; 343:d3805. [PMID: 21737469] doi:10.1136/bmj.d3805
7. Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, et al.; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008; 359:1464-76. [PMID: 18779236] doi:10.1056/NEJMoa0805017
8. Beck RW, Hirsch IB, Laffel L, Tamborlane WV, Bode BW, Buckingham B, et al.; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care. 2009; 32:1378-83. [PMID: 19429875] doi:10.2337/dc09-0108
9. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care. 2010; 33:17-22. [PMID: 19837791] doi:10.2337/dc09-1502
10. 1c in the ASPIRE In-Home study. Diabetes Technol Ther. 2015; 17:542-7. [PMID: 26237308] doi:10.1089/dia.2014.0306
11. Yeh HC, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, et al. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann Intern Med. 2012; 157:336-47. [PMID: 22777524]
12. Beck RW, Riddlesworth T, Ruedy K, Ahmann A, Bergenstal R, Haller S, et al.; DIAMOND Study Group. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA. 2017; 317:371-378. [PMID: 28118453] doi:10.1001/jama.2016.19975
13. American Diabetes Association. Statistics About Diabetes: Overall Numbers, Diabetes and Prediabetes. Accessed at www.diabetes.org/diabetes-basics/statistics on 6 February 2016.
14. Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States 2014. Atlanta: U.S. Department of Health and Human Services; 2014.
15. Nichols GA, Gandra SR, Chiou CF, Anthony MS, Alexander-Bridges M, Brown JB. Successes and challenges of insulin therapy for type 2 diabetes in a managed-care setting. Curr Med Res Opin. 2010; 26:9-15. [PMID: 19891525] doi:10.1185/03007990903417679
16. Selvin E, Parrinello CM, Daya N, Bergenstal RM. Trends in insulin use and diabetes control in the U.S.: 1988-1994 and 1999-2012 [Letter]. Diabetes Care. 2016; 39:e33-5. [PMID: 26721815] doi:10.2337/dc15-2229
17. Cariou B, Fontaine P, Eschwege E, Lièvre M, Gouet D, Huet D, et al. Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study. Diabetes Metab. 2015; 41:116-25. [PMID: 25465273] doi:10.1016/j.diabet.2014.10.007
18. Pazos-Couselo M, García-López JM, González-Rodríguez M, Gude F, Mayán-Santos JM, Rodríguez-Segade S, et al. High incidence of hypoglycemia in stable insulin-treated type 2 diabetes mellitus: continuous glucose monitoring vs. self-monitored blood glucose. Observational prospective study. Can J Diabetes. 2015; 39: 428-33. [PMID: 26254702] doi:10.1016/j.jcjd.2015.05.007
19. Vigersky RA, Fonda SJ, Chellappa M, Walker MS, Ehrhardt NM. Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes. Diabetes Care. 2012; 35:32-8. [PMID: 22100963] doi:10.2337/dc11-1438
20. Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther. 2017; 8:55-73. [PMID: 28000140] doi:10.1007/s13300-016-0223-6
21. 1C with real-time continuous glucose monitoring: results from a 12-week observational study. Diabetes Technol Ther. 2007; 9:203-10. [PMID: 17561790]
22. 1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor. Diabetes Care. 2006; 29:2644-9. [PMID: 17130198]
23. Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, et al. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care. 2006; 29:44-50. [PMID: 16373894]
24. Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, Polonsky W. Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care. 1995; 18:517-22. [PMID: 7497862]
25. EuroQol Research Foundation. EQ-5D-5L Instruments. Accessed at https://euroqol.org/eq-5d-instruments on 7 July 2017.
26. Hajos TR, Pouwer F, Skovlund SE, Den Oudsten BL, Geelhoed-Duijvestijn PH, Tack CJ, et al. Psychometric and screening properties of the WHO-5 well-being index in adult outpatients with Type 1 or Type 2 diabetes mellitus. Diabet Med. 2013; 30:e63-9. [PMID: 23072401] doi:10.1111/dme.12040
27. Irvine A, Cox DJ, Gonder-Frederick L. The fear of hypoglycaemia scale. In: Bradley C, ed. Handbook of Psychology and Diabetes. New York: Harwood; 1994:133-55.
28. Polonsky WH, Fisher L, Earles J, Dudl RJ, Lees J, Mullan J, et al. Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care. 2005; 28:626-31. [PMID: 15735199]
29. Polonsky WH, Fisher L, Hessler D, Edelman SV. Investigating hypoglycemic confidence in type 1 and type 2 diabetes. Diabetes Technol Ther. 2017; 19:131-136. [PMID: 27997217] doi:10.1089/dia.2016.0366
30. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Validation of measures of satisfaction with and impact of continuous and conventional glucose monitoring. Diabetes Technol Ther. 2010; 12:679-84. [PMID: 20799388]
31. Little RJA, Rubin DB. Statistical Analysis with Missing Data. New York: J Wiley; 1987:164-89, 260-65.
32. Schafer JL Analysis of Incomplete Multivariate Data. New York: Chapman & Hall; 1997.
33. Kleinman LC, Norton EC. What's the risk? A simple approach for estimating adjusted risk measures from nonlinear models including logistic regression. Health Serv Res. 2009; 44:288-302. [PMID: 18793213] doi:10.1111/j.1475-6773.2008.00900.x
34. Writing Team for the Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA. 2002; 287:2563-9. [PMID: 12020338]
35. Reznik Y, Cohen O, Aronson R, Conget I, Runzis S, Castaneda J, et al.; OpT2mise Study Group. Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial. Lancet. 2014; 384:1265-72. [PMID: 24998009] doi:10.1016/S0140-6736(14)61037-0
36. American Diabetes Association. Standards of medical care in diabetes 2016. Diabetes Care. 2016; 39(suppl 1):S1-S104.